Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent of coronavirus disease 2019 (COVID-19), which was declared a global …

• There are no specific therapies approved by the US Food and Drug Administration (FDA)
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes …

With the emergence of COVID-19 extensive research began to identify medications,
candidate compounds and other therapeutic approaches. The complex virology of COVID …

Introdução: Há diversas terapias sendo utilizadas, consideradas ou propostas para o
tratamento da COVID-19, muitas carecendo de apropriada avaliação de efetividade e …

Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

The emergence of SARS-CoV-2/2019 novel coronavirus (COVID-19) has created a global
pandemic with no approved treatments or vaccines. Many treatments have already been …

The coronavirus disease 2019 (COVID-19) pandemic continues to dominate our daily lives.
The “second wave” has slowed down in most regions around the globe, just to give way to …

SARS‐CoV‐2 has caused a pandemic which is putting strain on the health‐care system and
global economy. There is much pressure to develop both preventative and curative …

Background The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious
impact on public health worldwide. Most patients develop mild to moderate symptoms and …

BACKGROUND: Antiviral medications are being given empirically to some patients with
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …